We cannot guarantee that the content will display correctly while using Internet Explorer. To have the best browsing experience, please upgrade to Microsoft Edge, Google Chrome or Safari.

October 22, 2021

Where we see telehealth when the dust settles post-Covid 19: clinician and market insight.

Commentary
Frank Kenny BSc (Hons) Physiotherapy, MSc Sports Physiotherapy Chartered Physiotherapist
&

While many industries struggled to hold their ground in the midst of the COVID-19 pandemic, the healthcare industry thrived. In fact, the pandemic fuelled the transition towards telemedicine. With social distancing measures in place for months on end, strict stay-at-home orders, alongside higher demands and reduced capacity in healthcare systems, there was a dramatic swing towards telehealth following the start of the pandemic. 

Following on from our previous blog "The Telehealth [R]evolution" we now assess the current status of telehealth as the dust begins to settle nearly two years after the onset of the pandemic through the personal lens of a clinician.

 

How big was the swing to telehealth once COVID arrived?

 

Prior to the start of the pandemic, between 2009 and 2017, the percentage of hospitals fully or partially implementing computerized telehealth systems grew from 35% in 2010, to 76% in 2017. It can be said that rather than causing this increase in telehealth, the pandemic has catalysed this growth.

During my time as a clinician, I would have used telehealth on a small number of patients in the past before the pandemic. As recent research on the transition to telehealth has indicated, the switch at some healthcare centres was dramatic and often happened rapidly. In one example at a primary care centre the use of telehealth drastically increased. On the Friday, all primary care encounters were in-office visits. Contrastingly, on the following Monday, nearly 90% of consultations were taking place via telehealth..

Research using the data from The National Disease and Therapeutic Index comparing 2019 to Q2 2020 reported that use of telemedicine, which accounted for fewer than one in fifty of primary care visits during 2019, accounted for nearly two out of five visits during Q2 of 2020.


Personal experience of telehealth as a clinician


Personally, having worked as a physiotherapist, I have used telehealth in the past to provide care for patients with musculoskeletal complaints and neurological conditions. Consistently, patients have reported back to me at their surprise at how effective it has been. They enter the telehealth appointment with low expectations of its efficacy, but finish with an increased appreciation of what can be achieved via telehealth. Using digital telehealth platforms like Salaso and Physitrack were really valuable for both clinician and patient in telehealth appointments. They were also helpful in subsequent treatment adherence with patients really engaging with these digital solutions.

Interestingly, as a physiotherapist, an ever increasing evidence base in the management of certain conditions such as lower back pain appears to be pointing towards more active interventions such as exercise and education rather than hands on therapy and so telehealth is well suited to this space. From my personal experience on the ground in telehealth, I do feel that a blended approach with a mixture of face to face visits and telehealth works best. In particular, as it would enable you to undertake more in-depth assessments in face-to-face appointments such as neurological testing if required for some patients, minimising further the risk of diagnostic error.


Where is telehealth now and how is it positioned against challenges?


According to the Facts and Factors market report, the global telehealth market is expected to grow at 26.5% CAGR annually during 2021-2026. The global telemedicine market generated $40.20 billion in 2020, and is projected to reach a whopping $431.82 billion by 2030.

Growth in telehealth usage peaked in spring 2020 but has stabilised since. Telehealth has recently shown reduced insurance claims throughout the USA with the month of July versus June 2021 down 6%. Interestingly, mental health consistently appears to be the top diagnosis within all telehealth claims. 


It was thought that the complex FDA regulatory framework and technology adoption amongst elderly would be two key potential barriers to telehealth adoption and growth. However, by issuing a number of temporary policies, the FDA has looked to support digital health innovation during the pandemic, further favouring the use of telehealth services. They have also issued guidance documents to expand the use of digital therapeutics for psychiatric disorders and medical devices for remote patient monitoring during the pandemic. 


Similarly, the technology adoption that may have been perceived to be a barrier in older patients has actually been shown to be one in which they adapt quite well. According to the national poll on health aging, that focused on Telehealth Use Among Older Adults Before and During COVID-19, the vast majority (91%) found it easy to use the technology necessary to complete their telehealth visit, and 64% reported that they feel comfortable with video conferencing technologies (which is up from 53% in 2019.)


The digital divide continues to remain a barrier to telehealth adoption as not everyone has access to personal laptops or broadband even today. Interestingly, telehealth companies are starting to take initiatives to address this. For example, Babylon’s collaboration with Rwanda's National ID Agency (NIDA) to make digital consultation available to non-phone users or users using shared-devices is really noteworthy. As telehealth becomes all-pervasive there are calls for telecommunication devices to be covered as a medical necessity, especially given the correlation between poverty and telemedicine unreadiness


A hybrid future


Patients engaged very well with telehealth during COVID, with many reporting it to be comparably effective. However, with face-to-face medical visits returning, many patients feel the need for this more personal form of face-to-face care. Literature shows that virtual consultations have provided positive outcomes with good levels of patient satisfaction. Telehealth can also provide increased access to care and empower patients with chronic conditions to manage their conditions. There is a benefit too for healthcare organisations, as telehealth can improve adherence to medication, reduce missed appointment times and lessen wait times.

However, the fundamental challenge will be for policymakers to help the legislation catch up with the growth in technology through additional means of reimbursement for telehealth. Interestingly, pressure in this area is growing, as outlined in the recent CB insights report on the state of telehealth Q2 2021, showing a large increase in the number of lobbying reports particularly in the last twelve months as pressure continues to mount for long-term telehealth regulatory reform.


Telehealth improves outcomes, and in so doing improves public health. It is however not a panacea – with some areas of healthcare like mental health, more suited to it than others. There is also a hesitation around technology security that remains to be addressed. Due to these existing perceptions of telehealth, models are likely to evolve to optimize hybrid virtual and in-person care delivery, going forward.


Are you interested in learning more about TELEMEDICINE & VIRTUAL CARE DELIVERY? Join your peers at our upcoming digital health meeting on Commercialisation models for Virtual Care in Respiratory Diseases

03 Nov 2021


We can provide an introduction on your behalf so that you can contact them directly with any questions/queries on this topic. Simply click on the link below to request an introduction.

We can provide an introduction on your behalf so that you can contact them directly with any questions/queries on this topic. Simply click on the link below to request an introduction.

Request an Introduction

We can provide an introduction on your behalf so that you can contact them directly with any questions/queries on this topic. Simply click on the link below to request an introduction.

Request an Introduction

Ready to read more? HealthXL members can access the full peak of the report on the HealthXL Community Hub.

Not yet a member of HealthXL? Download your 11 page snapshot of the report.

Download your 11 page snapshot

Connect with peers and share insights

Don't miss out on the discussion of the latest insights and reports on digital health. Meet with peers and take a deep dive for 75 minutes. Unlike at webinars, you can freely exchange experiences and insights to solve challenges and design the future of DTx.

Digital Therapeutics (DTx)
Digital Therapeutics (DTx)
Digital Therapeutics (DTx)
Digital Therapeutics (DTx)

Masterclass: How to get your DTx product reimbursed in the US?

6th December @ 10:45AM EDT

Are you a DTx company seeking reimbursement in the US? Then this masterclass is for you. Join us in this US-focused interactive masterclass led by Mike Pace, who will walk us through how to get your DTx product reimbursed in the US.

Featuring
Michael Pace
Michael Pace
Founder and President at PalmHealth.co
Featuring
Michael Pace
Michael Pace
Founder and President at PalmHealth.co
Digital Therapeutics (DTx)
Digital Therapeutics (DTx)
Digital Therapeutics (DTx)
Digital Therapeutics (DTx)

Sprint: Best routes to market for DTx in the US

7th December @ 10:45AM EDT

Join us in this series of 2 meetings to discuss in detail with other senior leaders the best routes to market for DTx products in the US market. Apply now to be part of the conversation and shares your thoughts on the topic.

Featuring
Eugene Borukhovich
Eugene Borukhovich
Chairman and COO of YourCoach.Health
Kyloon Chuah
Kyloon Chuah
Co-Founder & CEO @ Veriteos
Featuring
Eugene Borukhovich
Eugene Borukhovich
Chairman and COO of YourCoach.Health
Kyloon Chuah
Kyloon Chuah
Co-Founder & CEO @ Veriteos
Digital Therapeutics (DTx)
Digital Therapeutics (DTx)
Digital Therapeutics (DTx)
Digital Therapeutics (DTx)

Masterclass: The regulation of DTx in the US

7th December @ 10:45AM EDT

Join us in this Masterclass led by AmalgamRx to learn more about the regulation of DTx in the US. Our Masterclasses are the perfect opportunity to hear valuable insights from thoughts leaders in the industry while also having the chance to share your own thoughts and experiences on the topic.

Featuring
Jason Brooke
Jason Brooke
General Counsel and VP of Regulatory and Quality, AmalgamRx
Featuring
Jason Brooke
Jason Brooke
General Counsel and VP of Regulatory and Quality, AmalgamRx
Digital Therapeutics (DTx)
Digital Therapeutics (DTx)
Digital Therapeutics (DTx)
Digital Therapeutics (DTx)

Webinar: DTx Commercialisation Models - Employer Partnerships

13th December @ 10:00AM EDT

Join us for this webinar where wewill present the key findings from our latest report followed by a panel discussion focused on DTx-Employer partnerships. Seats are limited, apply now to book your place!

Featuring
Eugene Borukhovich
Eugene Borukhovich
Chairman and COO of YourCoach.Health
Jonas Duss
Jonas Duss
US CEO, Co-Founder at Kaia Health
Featuring
Eugene Borukhovich
Eugene Borukhovich
Chairman and COO of YourCoach.Health
Jonas Duss
Jonas Duss
US CEO, Co-Founder at Kaia Health

Are you a HealthXL Member? See the Full Report Here

Non-HealthXL Member? You can purchase the report HERE

HealthXL Digital Health Meetings

Want to join the discussion now?

Join our Digital Health Meetings and take a deep dive for 75 minutes into topics like digital therapeutics, patient support, telehealth, clinical trials, dermatology and many more. These Meetings are not regular webinars: No audience, no recording and no hiding behind a screen. You actively participate in a discussion to solve your present challenges and design the future of digital health. And with a free account on our Community Hub, you stay connected and up-to-date on the latest news and insights, allowing you to fully immerse yourself in the topic before, during and after.

Digital Mental Health & Neurology
Digital Mental Health & Neurology
Digital Mental Health & Neurology
Digital Mental Health & Neurology

Innovation showcase: Digital Health Solutions for Depression & Anxiety

30th November @ 10:45AM EDT

Are you a digital health company working in the depression or anxiety space seeking guidance as you evolve your offerings? Apply now for the opportunity to showcase your products and services to possible investors/pharma partners, get advice from them and network with other digital health companies in this space.

Featuring
Jeff Weness
Jeff Weness
Head of Digital Opportunities and Business Intelligence at Otsuka
Sarah Fisher
Sarah Fisher
Senior Director, Global Markets, External Innovation, Johnson & Johnson Medical Devices
Featuring
Jeff Weness
Jeff Weness
Head of Digital Opportunities and Business Intelligence at Otsuka
Sarah Fisher
Sarah Fisher
Senior Director, Global Markets, External Innovation, Johnson & Johnson Medical Devices
Clinical Trials Innovation
Clinical Trials Innovation
Clinical Trials Innovation
Clinical Trials Innovation

Masterclass: Clinical Trials Design for Digital Health products

2nd December @ 10:45AM EDT

Join us in this Masterclass led by Curebase to learn more about Clinical Trials Design for Digital Health products. our Masterclass sessions offer you the opportunity to learn valuable insights from thought leaders in this space and answer any questions you may have on the topic.

Featuring
Eugene Borukhovich
Eugene Borukhovich
Chairman and COO of YourCoach.Health
Adam Samson
Adam Samson
Sr. Director of Clinical Operations & Customer Success
Featuring
Eugene Borukhovich
Eugene Borukhovich
Chairman and COO of YourCoach.Health
Adam Samson
Adam Samson
Sr. Director of Clinical Operations & Customer Success
Clinician and Patient Engagement & Support
Clinician and Patient Engagement & Support
Clinician and Patient Engagement & Support
Clinician and Patient Engagement & Support

Improving patient engagement in digital health

2nd December @ 11:30AM EDT

Join our Digital Health Meeting as we discuss the keys to successfully engaging patients with digital health tools. Perfect opportunity to connect with peers and share your own thoughts and experiences on the topic.

Featuring
Amanda Goltz
Amanda Goltz
Principal, Business Development, Alexa Health & Wellness at Amazon
Jo Masterson
Jo Masterson
Chief Executive Officer, 2Morrow, Inc.
Featuring
Amanda Goltz
Amanda Goltz
Principal, Business Development, Alexa Health & Wellness at Amazon
Jo Masterson
Jo Masterson
Chief Executive Officer, 2Morrow, Inc.
Digital Therapeutics (DTx)
Digital Therapeutics (DTx)
Digital Therapeutics (DTx)
Digital Therapeutics (DTx)

Masterclass: How to get your DTx product reimbursed in the US?

6th December @ 10:45AM EDT

Are you a DTx company seeking reimbursement in the US? Then this masterclass is for you. Join us in this US-focused interactive masterclass led by Mike Pace, who will walk us through how to get your DTx product reimbursed in the US.

Featuring
Michael Pace
Michael Pace
Founder and President at PalmHealth.co
Featuring
Michael Pace
Michael Pace
Founder and President at PalmHealth.co

What’s a Rich Text element?

The rich text element allows you to create and format headings, paragraphs, blockquotes, images, and video all in one place instead of having to add and format them individually. Just double-click and easily create content.

Static and dynamic content editing

A rich text element can be used with static or dynamic content. For static content, just drop it into any page and begin editing. For dynamic content, add a rich text field to any collection and then connect a rich text element to that field in the settings panel. Voila!

How to customize formatting for each rich text

Headings, paragraphs, blockquotes, figures, images, and figure captions can all be styled after a class is added to the rich text element using the "When inside of" nested selector system.

We cannot guarantee that the content will display correctly while using Internet Explorer. To have the best browsing experience, please upgrade to Microsoft Edge, Google Chrome or Safari.